Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Lymphedema Prevention in Breast Cancer

NCT00760123

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations: Alcalá University Alcalá de Henares, Madrid, Spain

María Torres Lacomba Alcalá de Henares, Madrid, Spain

View Trial Details

Completed

Metabolic Syndrome in Childhood Cancer Survivors

NCT00920738

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +49 more
Locations: University of Minnesota Children's Hospital - Fairview Minneapolis, Minnesota, United States

View Trial Details

Completed

Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer

NCT01499303

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Research Site Huntsville, Alabama, United States

Research Site Denver, Colorado, United States

Research Site New Haven, Connecticut, United States

Research Site Sarasota, Florida, United States

View all 21 locations

View Trial Details

Completed

Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET

NCT00583323

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Not specified

View Trial Details

Completed

Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL

NCT00854568

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +16 more
Locations: Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma

NCT00576758

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Los Angeles, California, United States

Denver, Colorado, United States

Gainesville, Florida, United States

Tampa, Florida, United States

View all 71 locations

View Trial Details

Completed

Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia

NCT00021242

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States

University of South Alabama Cancer Research Institute Mobile, Alabama, United States

Phoenix Children's Hospital Phoenix, Arizona, United States

Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States

View all 228 locations

View Trial Details

Completed

Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia

NCT00003933

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Long Beach Memorial Medical Center Long Beach, California, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

Children's Hospital of Orange County Orange, California, United States

View all 41 locations

View Trial Details

Completed

Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma

NCT00621452

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +38 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00110071

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +46 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions